463 related articles for article (PubMed ID: 26622051)
1. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
[TBL] [Abstract][Full Text] [Related]
2. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.
Kapoor D; Clarke S; Stanworth R; Channer KS; Jones TH
Eur J Endocrinol; 2007 May; 156(5):595-602. PubMed ID: 17468196
[TBL] [Abstract][Full Text] [Related]
3. Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.
Ghanim H; Dhindsa S; Batra M; Green K; Abuaysheh S; Kuhadiya ND; Makdissi A; Chaudhuri A; Sandhu S; Dandona P
J Clin Endocrinol Metab; 2020 Apr; 105(4):1169-75. PubMed ID: 31858126
[TBL] [Abstract][Full Text] [Related]
4. Hypogonadotropic Hypogonadism in Men With Diabesity.
Dhindsa S; Ghanim H; Batra M; Dandona P
Diabetes Care; 2018 Jul; 41(7):1516-1525. PubMed ID: 29934480
[TBL] [Abstract][Full Text] [Related]
5. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
7. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
[TBL] [Abstract][Full Text] [Related]
8. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism.
Naharci MI; Pinar M; Bolu E; Olgun A
Endocr Pract; 2007 Oct; 13(6):629-35. PubMed ID: 17954419
[TBL] [Abstract][Full Text] [Related]
9. Diminished androgen and estrogen receptors and aromatase levels in hypogonadal diabetic men: reversal with testosterone.
Ghanim H; Dhindsa S; Abuaysheh S; Batra M; Kuhadiya ND; Makdissi A; Chaudhuri A; Dandona P
Eur J Endocrinol; 2018 Mar; 178(3):277-283. PubMed ID: 29339527
[TBL] [Abstract][Full Text] [Related]
10. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
Magnussen LV
Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
[TBL] [Abstract][Full Text] [Related]
11. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity].
Mao JF; Wu XY; Li NS; Lu SY; Jing ZM; Shi YF
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2550-2. PubMed ID: 19080648
[TBL] [Abstract][Full Text] [Related]
12. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
Magnussen LV; Hvid LG; Hermann AP; Hougaard DM; Gram B; Caserotti P; Andersen MS
Andrology; 2017 Sep; 5(5):946-953. PubMed ID: 28914503
[TBL] [Abstract][Full Text] [Related]
13. The effects of testosterone replacement therapy in men with age-dependent hypogonadism on body composition, and serum levels of leptin, adiponectin, and C-reactive protein.
Dudek P; Kozakowski J; Zgliczyński W
Endokrynol Pol; 2020; 71(5):382-387. PubMed ID: 32797473
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
15. Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters.
Dias JP; Shardell MD; Carlson OD; Melvin D; Caturegli G; Ferrucci L; Chia CW; Egan JM; Basaria S
Andrology; 2017 Jan; 5(1):31-40. PubMed ID: 27792869
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
Gopal RA; Bothra N; Acharya SV; Ganesh HK; Bandgar TR; Menon PS; Shah NS
Endocr Pract; 2010; 16(4):570-6. PubMed ID: 20150021
[TBL] [Abstract][Full Text] [Related]
17. Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.
Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Green K; Makdissi A; Chaudhuri A; Dandona P
Clin Endocrinol (Oxf); 2016 Nov; 85(5):772-780. PubMed ID: 27292585
[TBL] [Abstract][Full Text] [Related]
18. Central body fat changes in men affected by post-surgical hypogonadotropic hypogonadism undergoing testosterone replacement therapy are modulated by androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Buldreghini E; Lenzi A; Balercia G
Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):908-13. PubMed ID: 24787905
[TBL] [Abstract][Full Text] [Related]
19. Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.
Reddy KC; Yadav SB
J Postgrad Med; 2021; 67(2):67-74. PubMed ID: 33942770
[TBL] [Abstract][Full Text] [Related]
20. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.
Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S; Mohanty P
Curr Mol Med; 2008 Dec; 8(8):816-28. PubMed ID: 19075678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
